Stereotaxis (STXS) EBT Growth (3y) (2013 - 2026)
Stereotaxis (STXS) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 30.64% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -58.07% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 20.18% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.48% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -39.89% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.41% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -34.42% |
| 10 | Stereotaxis | 180.48 Mn | 165.86 Mn | 3.79 Mn | -2.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.10% |
| Dec 31, 2025 | -8.23% |
| Sep 30, 2025 | -9.08% |
| Jun 30, 2025 | 8.43% |
| Mar 31, 2025 | -13.18% |
| Dec 31, 2024 | -31.57% |
| Sep 30, 2024 | -11.16% |
| Jun 30, 2024 | -21.09% |
| Mar 31, 2024 | -45.90% |
| Dec 31, 2023 | -65.19% |
| Sep 30, 2023 | -53.37% |
| Jun 30, 2023 | -40.03% |
| Mar 31, 2023 | -39.89% |
| Dec 31, 2022 | -55.43% |
| Sep 30, 2022 | -396.78% |
| Jun 30, 2022 | -53.65% |
| Mar 31, 2022 | -24.42% |
| Dec 31, 2021 | -80.45% |
| Sep 30, 2021 | -241.21% |
| Jun 30, 2021 | -75.05% |